Patient Safety and Risk Management
Stragen’s activities as a pharmaceutical laboratory are carried out within a regulated framework at every stage of a drug’s lifecycle, while adhering to latest regulatory requirements (registration, interactions with all EU health authorities, and market access) and quality standards (product compliance, monitoring, supplier and third-party quality management).
In terms of safety, our medications comply with European regulations. All of our medications are serialized and equipped with a tamper-evident system on each box. Our pharmacovigilance system continuously monitor the benefit-risk balance of our medications meeting national and European regulatory requirements.
For all adverse event suspicion or a security issue of one of our products, please follow the reporting pharmacovigilance procedure indicated below:
If you suspect an adverse drug reaction, dosage or administration error, misuse, etc., please contact Stragen’s pharmacovigilance department.
- Medical Information please call: 01271 334 609
- Email: firstname.lastname@example.org
- For Pharmacovigilance, contact: email@example.com
Pharmacovigilance is vital in guaranteeing the safety of medical products. Reportings are essential to ensure a continuous monitoring and in improving the safety of medications. Please feel free to contact our pharmacovigilance team if you have any concerns or questions.